Morimoto C - Search Results

1

A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target.

Ohnuma K, Hatano R, Komiya E, Otsuka H, Itoh T, Iwao N, Kaneko Y, Yamada T, Dang NH, Morimoto C. Ohnuma K, et al. Among authors: morimoto c. Front Biosci (Landmark Ed). 2018 Jun 1;23(9):1754-1779. doi: 10.2741/4671. Front Biosci (Landmark Ed). 2018. PMID: 29772527 Free article. Review.

2

CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation.

Torimoto Y, Rothstein DM, Dang NH, Schlossman SF, Morimoto C. Torimoto Y, et al. Among authors: morimoto c. J Immunol. 1992 Jan 15;148(2):388-96. J Immunol. 1992. PMID: 1345920

3

Cloning and functional expression of the T cell activation antigen CD26.

Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman SF, Morimoto C. Tanaka T, et al. Among authors: morimoto c. J Immunol. 1992 Jul 15;149(2):481-6. J Immunol. 1992. PMID: 1352530

4

Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies.

Torimoto Y, Dang NH, Tanaka T, Prado C, Schlossman SF, Morimoto C. Torimoto Y, et al. Among authors: morimoto c. Mol Immunol. 1992 Feb;29(2):183-92. doi: 10.1016/0161-5890(92)90099-j. Mol Immunol. 1992. PMID: 1371820

5

Activation of T cells through a T cell-specific epitope of CD45.

Torimoto Y, Dang NH, Streuli M, Rothstein DM, Saito H, Schlossman SF, Morimoto C. Torimoto Y, et al. Among authors: morimoto c. Cell Immunol. 1992 Nov;145(1):111-29. doi: 10.1016/0008-8749(92)90317-i. Cell Immunol. 1992. PMID: 1384991

6

Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.

Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C. Torimoto Y, et al. Among authors: morimoto c. J Immunol. 1991 Oct 15;147(8):2514-7. J Immunol. 1991. PMID: 1680916

7

Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system.

Yamada A, Nojima Y, Sugita K, Dang NH, Schlossman SF, Morimoto C. Yamada A, et al. Among authors: morimoto c. Eur J Immunol. 1991 Feb;21(2):319-25. doi: 10.1002/eji.1830210212. Eur J Immunol. 1991. PMID: 1705510

8

Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells.

Torimoto Y, Sugita K, Weinberg DS, Dang NH, Donahue C, Letvin NL, Schlossman SF, Morimoto C. Torimoto Y, et al. Among authors: morimoto c. J Immunol. 1991 Apr 1;146(7):2176-84. J Immunol. 1991. PMID: 1706389

9

1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.

Dang NH, Torimoto Y, Shimamura K, Tanaka T, Daley JF, Schlossman SF, Morimoto C. Dang NH, et al. Among authors: morimoto c. J Immunol. 1991 Nov 1;147(9):2825-32. J Immunol. 1991. PMID: 1717577

10

Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.

Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C. Dang NH, et al. Among authors: morimoto c. J Immunol. 1990 Jun 1;144(11):4092-100. J Immunol. 1990. PMID: 1971293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

533 results

Search Page

Filters